Effects of the antipsychotic drug sulpiride on reproductive hormones in healthy men: Relationship with body weight regulation

Pharmacopsychiatry

Volumn 30, Issue 6, 1997, Pages 250-255

  Baptista, T ^a,d   Alastre, T ^a   Contreras, Q ^a   Martinez, J L ^b   Araujo De Baptista, E ^c   Paez X ^a   Hernandez L ^a  

^a UNIVERSIDAD DE LOS ANDES   (Venezuela)

^b Medical School

^c Pharmacy School

^d NONE   (Venezuela)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; HYDROCORTISONE; PLACEBO; PRASTERONE SULFATE; PROLACTIN; SULPIRIDE; TESTOSTERONE; THYROID HORMONE; THYROTROPIN;

ADULT; ARTICLE; BODY WEIGHT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; ENDOCRINE DISEASE; HORMONE BLOOD LEVEL; HORMONE RELEASE; HUMAN; HUMAN EXPERIMENT; HYPERPROLACTINEMIA; LIPID BLOOD LEVEL; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; VOLUNTEER; WEIGHT GAIN;

EID: 0031441384     PISSN: 01763679     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-979502     Document Type: Article

References (38)

1. Bhavnani, S. M., G. M. Levin: Antipsychotic agents: a survey of the prevalence, severity and burden of side effects. Int. Clin. Psychopharmacol. 11 (1996) 1-12
2. 2 dopamine receptors involved? Pharmacol. Biochem. Behav. 27 (1987) 399-405
3. Baptista, T., M. A. Parada, E. Murzi: Puberty modifies sulpiride effects on body weight in rats. Neurosci. Lett. 92 (1988) 161-164
4. Baptista, T., L Hernández, B. G. Hoebel: Systemic sulpiride increases dopamine metabolites in the lateral hypothalamus. Pharmacol. Biochem. Behav. 37 (1990) 227-229
5. Baptista, T., L. Teneud, L. Hernández: Enhancement of amphetamine anorexia after chronic administration of sulpiride in rats. Pharmacol. Biochem. Behav. 45 (1993) 45-49
6. Baptista, T., L. Teneud, Q. Contreras, T. Alastre, J. L. Burguera, M. Burguera, E. de Baptista, S. R. B. Weiss, L. Hernández: Lithium and body weight gain. Pharmacopsychiat. 28 (1995) 35-44
7. Beumont, P. J. V., C. S. Corker, H. G. Friesen, T Kakowska, B. M. Mandelbrote, J. Marshall, M. A. F. Murray, D. H. Wiles: Effects of phenothiazines on endocrine function: II: effects in men and post-menopausal women. Brit. J. Psychiat. 124 (1974) 420-430
8. Björntorp, P.: Endocrine abnormalities of obesity. Metabolism 44 (1995) 21-23 (Suppl.).
9. Borison, R. L., A. P. Pathiraja, B. I. Diamond, R. C. Meibach: Risperidone: clinical safety and efficacy in schizophrenia. Psychopharmacol. Bull. 28 (1992) 213-218
10. Brown, A. A., T. P. Laughren, B. Williams: Differential effects of neuroleptic agents on the pituitary-gonadal axis in men. Arch. Gen. Psychiatry. 38 (1981) 1270-1272
11. Cabrera, R., P. Mayor, J. Fernández-Ruiz, C. Calle: Insulin binding and action on adipocytes from female rats with experimentally induced chronic hyperprolactinemia. Mol. Cell Endocrinol. 58 (1988) 167-173
12. Correa, N., L. A. Opler, S. R. Kay, B. Birmaher: Amantadine in the treatment of neuroendocrine side effects of neuroleptics. J. Clin. Psychopharmacol. 7 (1987) 91-95
13. Erhardt, V. R., M. B. Goldman: Adverse endocrine effects. In Keshavan, S., J. S. Kennedy: Drug-induced dysfunction in Psychiatry. Hemis. Publ. Corp. New York (1992) 293-310
14. Fitton, A., R. C. Heel: Clozapine. A review of its pharmacological properties, and thrapeutic use in schizophrenia. Drugs 40 (1990) 723-747
15. Gerardo-Gettens, T., B. J. Moore, J. S. Stern, B. A. Horwitz: Prolactin stimulates intake in a dose-dependent manner. Am. J. Physiol. 256 (1989) R 276-280
16. Chadirian, M., G. Chouinard, I. Annable: Sexual dysfunction and plasma prolactin levels in neuroleptic-treated schizophrenic outpatients. J. Nerv. Ment. Dis. 170 (1982) 463-467
17. Goodall, E., C. Oxtoby., R. Richards., G. Watkinson., D. Brown, T. Silverstone: A clinical trial on the efficacy and acceptability of D-fenfluramine in the treatment of neuroleptic-induced obesity. Brit. J. Psychiat. 153 (1988) 208-213
18. Gopalaswamy, A. K., R. Morgan: Too many chronic mentally disabled patients are too fat. Acta Psychiat. Scand. 72 (1985) 254-258
19. Green, A. I., W. A. Brown: Prolactin and neuroleptic drugs. Neurologic Clin. 6 (1988) 213-223
20. Johnson, R. D: Opioid involvement in feeding behavior and the pathogenesis of certain eating disorders. Med. Hypotheses. 45 (1995) 491-497
21. Kissebah, A. H., G. R. Krakover: Regional adiposity and morbidity. Physiol. Rev. 74 (1994) 761-798
22. Legros, J. J., A. Demoulin, P. Franchimont: Influence of chlorpromazine on the positive and negative feed-back mechanism of oestrogens in man. Psychoneuroendocrinol. 1 (1985) 185-198
23. L'Hermite, M., P. Denayer, J. Golstein, E. Virasoro, I. Vanhaelst, G. Copinschi, C. Robyn: Acute endocrine profile of sulpiride in the human. Clin. Endocrinol. 9 (1978) 195-204
24. Mendoza, S., C. G. A. Scwazemberg, A. Zerpa, E. Velazquez, C. J. Glueck: Lipids, lipoproteins, and sex hormones in obese men: its relationship. Int. J. Obesity. 10 (1986) 427-431
25. Murzi, E., T. Baptista, L. Hernandez: Hypothalamic sites affecting masticatory neurons in rats. Brain Res. Bull. 26 (1991) 321-325
26. Nestler, J. E., C. O. Barlascini, J. N. Clore: Dehydroepiandrosterone reduces serum low density lipoprotein levels and body fat but does not alter insulin sensitivity in normal men. J. Clin. Endocrinol. Metab. 66 (1988) 57-61
27. Okonmah, A. D., W. G. Bradashaw, P. Couceyro, K. F. A. Soliman: The effect of neuroleptic drugs on serum testosterone level in the male rat. Gen. Pharmacol. 17 (1986) 235-239
28. Parada, M. A., L. Hernández, B. G. Hoebel: Sulpiride injections in the lateral hypothalamus induce feeding and drinking in rats. Pharmacol. Biochem. Behav. 30 (1988) 917-923
29. Parada, M. A., L. Hernández, X. Páez, T. Baptista, M. Puig de Parada, M. Quijada: Mechanism of the sulpiride-induced obesity. Pharmacol. Biochem. Behav. 33 (1989) 45-50
30. Rinieris, P., M. Markianos, J. Hatzimanolis, C. Stefanis: A psychoendocrine study in male paranoid schizophrenics with delusional ideas of homosexual content. Acta Psychiat. Scand. 3 (1985) 309-314
31. Roberts, S. R., A. S. Greenberg: The new obesity genes. Nutr. Rev. 54 (1996) 41-49
32. Robinson, R. G., P. R. McHugh, M. E. Folstein: Measurement of appetite disturbances in psychiatric disorders. J. Psychiat. Res. 12 (1975) 59-68
33. Ruiz, E., E. Ortega, C. Mendoza, C. Osorio: Effects of Sulpiride on levels of FSH, LH and steroid hormones. Revista Española de Fisiologia 40 (1984) 243-248
34. 2 receptor antagonist sulpiride. Exp. Clin. Endocrinol. 96 (1990) 25-29
35. Silva, E., M. Catalán, L. Hernández, L. Teneúd, T. Baptista: Hyponatremia and neuroleptic-induced obesity in rats. Research Comm. Mol. Pathol. & Pharmacol. 85 (1994) 237-240
36. Sletten, I. W., S. Gherson: The effect of chlorpromazine on water and electrolyte balance. J. Nerv. Ment. Dis. 142 (1966) 25-31
37. Spark, R., C. Wills, G. Reilly, B. Ransil:. Hyperprolactinemia in males with and without pituitary microadenomas. Lancet 17 (1982) 129-131
38. Wade, G. N., J. M. Gray: Gonadal effects on food intake and adiposity: a metabolic hypothesis. Physiol. Behav. 22 (1979) 583-594